about
Monocarboxylate transporter 1 inhibitors as potential anticancer agentsSynthesis and biological evaluation of 2-alkoxycarbonylallyl esters as potential anticancer agents.Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agentsSynthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents.A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinomaDevelopment of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer TreatmentPrexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
P50
Q35615147-10B65B42-A483-4B97-B7F9-CA776FB39851Q38719087-B3BD5AAF-A00B-42AF-8DE6-2F4D4CE2CD2BQ38767434-B1BE51B0-6277-4BBB-A140-B49C9D1A67B6Q38819988-F6CF2B09-576A-49D0-AA9F-673AF0331CE8Q90986886-E8B16691-5AD6-4264-90BF-71CDCA73BFE5Q91665666-A97153BB-D8B6-44F8-88DF-11215F458DC3Q93157621-6D22597F-17B0-42CD-967C-8C3FD23E2C3B
P50
description
investigador
@es
researcher
@en
name
Sravan K Jonnalagadda
@en
type
label
Sravan K Jonnalagadda
@en
prefLabel
Sravan K Jonnalagadda
@en
P31
P496
0000-0002-5403-4383